Hallucinogen abuse with intoxication with perceptual disturbance
ICD-10 F16.122 is a billable code used to indicate a diagnosis of hallucinogen abuse with intoxication with perceptual disturbance.
F16.122 refers to a condition characterized by the abuse of hallucinogenic substances, leading to intoxication that manifests as perceptual disturbances. Hallucinogens, such as LSD, psilocybin, and mescaline, can alter an individual's perception of reality, causing visual and auditory hallucinations, altered sense of time, and profound changes in thought processes. The intoxication phase can lead to significant impairment in social and occupational functioning, as well as potential harm to oneself or others. Symptoms may include anxiety, paranoia, and confusion, which can escalate to more severe psychological disturbances. Treatment often involves supportive care, counseling, and in some cases, medication to manage acute symptoms. Long-term management may require participation in substance use disorder treatment programs, including cognitive-behavioral therapy and support groups, to address underlying issues related to addiction and to prevent relapse.
Detailed patient history, including substance use patterns and mental health evaluations.
Patients presenting with acute psychosis or severe anxiety following hallucinogen use.
Documentation must clearly outline the relationship between hallucinogen use and psychiatric symptoms.
Comprehensive assessment of substance use, including frequency, duration, and impact on functioning.
Patients seeking treatment for hallucinogen dependence or those experiencing withdrawal symptoms.
Focus on treatment plans that address both addiction and any co-occurring mental health disorders.
Used when a patient with hallucinogen abuse presents for follow-up care.
Document the patient's substance use history, current symptoms, and treatment plan.
Psychiatry may require additional mental health assessments.
Key symptoms include visual and auditory hallucinations, altered perception of time and space, anxiety, paranoia, and changes in thought processes.